⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

KURA News

Kura Oncology, Inc.

Kura Oncology and Kyowa Kirin Announce Publication of Pivotal Ziftomenib Data in Relapsed/Refractory NPM1-Mutated AML in the Journal of Clinical Oncology